Education, Science, Technology, Innovation and Life
Open Access
Sign In

Case of Ovarian Cancer Complicated with Cancerous Ascites Treated by TCM Syndrome Differentiation and Western Medicine

Download as PDF

DOI: 10.23977/medsc.2022.030708 | Downloads: 12 | Views: 461

Author(s)

Jingya Fu 1, Haijuan Xiao 1, Yuyuan Ma 1

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China

Corresponding Author

Haijuan Xiao

ABSTRACT

Ovarian cancer is one of the common gynecological tumors in clinical practice, and cancer associates is a common complication in the late stage. Western medicine treatment is limited and ineffective, and TCM syndrome differentiation can significantly enhance clinical efficacy. The basis for ovarian cancer patients with postoperative recurrence merger cancerous ascites, belongs to the category of "accumulation" and "ballooning". This paper is given priority to introduce the settlement method of shaoyang, according to the different diseases concurrently, shall fall under the inverse gas qi and blood, spleen wet and double fill treatment, with western medicine comprehensive treatment of the disease, curative effect is satisfied, tumor markers have fallen sharply, so the author makes the basis as follows, to learn and communicate with peers.

KEYWORDS

Ovarian Cancer, Cancerous Ascites, Dialectical Treatment

CITE THIS PAPER

Jingya Fu, Haijuan Xiao, Yuyuan Ma, Case of Ovarian Cancer Complicated with Cancerous Ascites Treated by TCM Syndrome Differentiation and Western Medicine. MEDS Clinical Medicine (2022) Vol. 3: 44-51. DOI: http://dx.doi.org/10.23977/medsc.2022.030708.

REFERENCES

[1] Li Dan, Zhang Hong. (2020) Clinical research progress in the pathogenesis and immunotherapy of ovarian cancer. Journal of practical obstetrics and gynecology, 12, 908-911.
[2] Zhao Jing, Zhang Qin, Liu Jian, Wang Hailin.(2021) Research progress in the pathogenesis and targeted therapy of endometriosis associated ovarian cancer [J]. Chinese journal of clinical new medicine, 11, 1147-1150.
[3] Jiang T, Wang B B, Wang B B. (2021) Experience in the treatment of postoperatively associated menopausal syndrome with ovarian cancer. Zhejiang journal of integrated traditional Chinese and western medicine, 02, 179-181.
[4] Yan Mengyu, Shen Ying, Han Fengjuan. (2020)An analysis of the pathogenesis of ovarian cancer from the perspective of emotional factors. Liaoning journal of traditional Chinese medicine, 10, 71-73.
[5] Wu X Q, Lu W P. (2020) Study on the pathogenesis and treatment of ovarian cancer based on Yang deficiency. China medical review, 34, 123-126.
[6] Xu Guo-shu, XIE Xin-ling, Chen Jiabin, YU Zhi-hong, ZHAN Yi-Ping, HU Qin-Qin, CHAI KQ. (2021)Chai kequn's experience in treating ovarian cancer based on the liver. Journal of traditional Chinese medicine oncology, 01, 38-42.
[7] Li Jiahe, Zhang Yao, Jia Yingjie, Guo Shanqi. (2020)Professor Jia Ying Jie's experience in distinguishing and treating cancer ascites based on "blood is not good for water". Journal of Tianjin university of traditional Chinese medicine, 04, 381-384.
[8] Xiong Xiaomei, He Liyuan, Long Shuailan, You Fengming. (2020)Discussion on the treatment of cancer ascites based on the method of removing blood stasis in the theory of blood syndrome [J]. Journal of traditional Chinese medicine oncology, 02, 67-70.
[9] Liu Yong, Liu Qing, Xia Liming. (2018)Clinical journal of traditional Chinese medicine, 11, 2033-2036. 
[10] Wang Xin-wen, YAO Yan Ru, DONG Xin-gang, KONG Wei-Wei, LI Pei-wen.(2018) Li peiwen's experience in the treatment of cancer pleural effusion with lobelia and barizeria [J]. Shanxi journal of traditional Chinese medicine, 04, 6-8.
[11] Zhang B, Zhou J H. (2017) Clinical journal of traditional Chinese medicine, 08, 1354-1357.
[12] Zhang Jie, Wang Libo, Wang Chenglong, Hu Yuehang, Qi Cong. (2021)Based on tumor immune micro environment research progress of traditional Chinese medicine treatment for ovarian cancer metastasis [J]. Journal of liaoning university of traditional Chinese medicine, 10, 111-115.
[13] Zhang H, Feng X X, Wang Y W, Miao F, Chao X. (2021) Application of traditional Chinese medicine therapy in adverse reactions after chemotherapy. Journal of Changchun university of traditional Chinese medicine, 02, 443-446.
[14] Ma Na, Liu Likun. (2021) Liu Tikun's experience in the treatment of breast cancer with small bupleurum decoction. Chinese folk therapy, 05, 23-25.
[15] Zhang Zhixiong, Liu Chunfang, Liu Mingyang, Kong Qinghui. (2021) Research progress on pharmacological action and clinical application of xiaobupleurum decoction. Clinical journal of traditional Chinese medicine, 03, 580-584.
[16] Dai C Y. (2014) Therapeutic effect of Wuling powder combined with intraperitoneal hyperthermic chemotherapy on advanced cancer ascites. Zhejiang journal of integrated traditional Chinese and western medicine, 12, 1089-1090.

Downloads: 3912
Visits: 170378

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.